from Wiktionary, Creative Commons Attribution/Share-Alike License
- n. A chimeric monoclonal antibody being investigated for the treatment of chronic lymphocytic leukemia.
● Lumiliximab: Completed enrollment in the Phase 2 portion of LUCID, a registration Phase 2 / 3 trial of lumiliximab in patients with relapsed or refractory chronic lymphocytic leukemia
The drivers of this increase included a $20 million milestone payment to Cardiokine and the continued progression of our late stage pipeline with investments to support Lixivaptan, BG-12, the peg interferon program and Galiximab and lumiliximab.
Accordingly we decided to stop recruitment in the lumiliximab LUCID trial and prematurely end the Galiximab target trial.